Plain-English translation of NCT06614270 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This trial is testing a new treatment called cells for people with severe autoimmune diseases that have not responded to standard medications. These are specialized immune cells grown in the laboratory and designed to target and reduce the cells causing your autoimmune condition. The study will assess whether this treatment is safe and effective for conditions like lupus, scleroderma, vasculitis, and similar diseases.
Many people with autoimmune diseases do not improve enough with existing treatments, and their conditions continue to cause serious damage. This trial exists to explore whether this new cell-based therapy can help patients whose diseases have become resistant to standard care.
You likely qualify if…
You likely don't qualify if…
If you are enrolled, you will receive infusions of the engineered immune cells at the hospital. The trial is designed to test increasing doses in small groups to ensure safety. You will have regular follow-up visits and blood tests to monitor how you respond and watch for any side effects. The exact duration and schedule of visits will be explained during screening.
AI-generated summary from trial data · Jun 2, 2026 · Not medical advice
China